![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 7, 4713-4721, February 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
from Human
Monocytes*
,
From the Department of Biochemistry, Faculty of Health Sciences,
McMaster University, Hamilton, Ontario L8N 3Z5, Canada
Liver X receptor
(LXR
), is a
nuclear hormone receptor that is activated by oxysterols and plays a
crucial role in regulating cholesterol and lipid metabolism in liver
and cholesterol efflux from lipid-loaded macrophages. Here we show that
treatment of human peripheral blood monocytes or monocytic THP-1 cells
with the LXR ligand 22(R)-hydroxycholesterol
(22(R)-HC), in combination with 9-cis-retinoic
acid (9cRA), a ligand for the LXR heterodimerization partner retinoid X
receptor (RXR), results in the specific induction of the potent
pro-apoptotic and pro-inflammatory cytokine tumor necrosis factor-
(TNF-
). Promoter analysis, inhibitor studies, and order-of-addition
experiments demonstrated that TNF-
induction by 22(R)-HC
and 9cRA occurs by a novel two-step process. The initial step involves
22(R)-HC-dependent induction of TNF-
mRNA, and intracellular accumulation of TNF-
protein, mediated
by binding of LXR
/RXR
to an LXR response element at position
879 of the TNF-
promoter. Subsequent cell release of TNF-
protein occurs via a separable 9cRA-dependent,
LXR
-independent step that requires de novo transcription
and protein synthesis. Our findings reveal a potentially new dimension
of the physiological role of LXR
and identify a unique multistep
pathway of TNF-
production that may be of consequence to the normal
function of LXR in monocyte/macrophages and in disease conditions such
as atherosclerosis.
Holds an Ontario Graduate Scholarship from the Province of Ontario.
§
To whom correspondence should be addressed: Tel.: 905-525-9140 (ext. 22184); Fax: 905-546-0800; E-mail: caponej@mcmaster.ca.
This article has been cited by other articles:
![]() |
C. J Delvecchio and J. P Capone Protein kinase C {alpha} modulates liver X receptor {alpha} transactivation J. Endocrinol., April 1, 2008; 197(1): 121 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fontaine, E. Rigamonti, A. Nohara, P. Gervois, E. Teissier, J.-C. Fruchart, B. Staels, and G. Chinetti-Gbaguidi Liver X Receptor Activation Potentiates the Lipopolysaccharide Response in Human Macrophages Circ. Res., July 6, 2007; 101(1): 40 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Mooijaart, M. Kuningas, R. G. J. Westendorp, J. J. Houwing-Duistermaat, P. E. Slagboom, P. C. N. Rensen, and D. van Heemst Liver X Receptor Alpha Associates With Human Life Span J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 343 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Neels, M. Pandey, G. S. Hotamisligil, and F. Samad Autoamplification of Tumor Necrosis Factor-{alpha}: A Potential Mechanism for the Maintenance of Elevated Tumor Necrosis Factor-{alpha} in Male but Not Female Obese Mice Am. J. Pathol., February 1, 2006; 168(2): 435 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bernstein, C. M. Payne, K. Kunke, C. L. Crowley-Weber, C. N. Waltmire, K. Dvorakova, H. Holubec, C. Bernstein, R. R. Vaillancourt, D. A. Raynes, et al. A proteomic study of resistance to deoxycholate-induced apoptosis Carcinogenesis, May 1, 2004; 25(5): 681 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Steffensen and J.-A. Gustafsson Putative Metabolic Effects of the Liver X Receptor (LXR) Diabetes, February 1, 2004; 53(90001): S36 - 42. [Abstract] [Full Text] |
||||
![]() |
R. K. Tangirala, E. D. Bischoff, S. B. Joseph, B. L. Wagner, R. Walczak, B. A. Laffitte, C. L. Daige, D. Thomas, R. A. Heyman, D. J. Mangelsdorf, et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis PNAS, September 3, 2002; 99(18): 11896 - 11901. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |